Co-Diagnostics, Inc. — Director's Dealing 2018

Apr 12, 2018

SEC Form 4/A — Form 4/A

Issuer: Co-Diagnostics, Inc. (CODX)
CIK: 0001692415
Period of Report: 2018-04-09

Reporting Person: Satterfield Brent (Director, Chief Science Officer, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-04-09	Common Stock	P	2400	$2.05	Acquired	2272198	Direct